View Post

Pfizer, Germany’s Merck begin large ovarian cancer trial

In In The News by Barbara Jacoby

Published by Reuters From: foxnews.com Pfizer Inc and German drugmaker Merck KGaA on Wednesday said they had begun a late-stage trial of their immuno-oncology drug avelumab in combination with standard treatment for ovarian cancer. The 950-patient study will enroll patients with advanced ovarian cancer who have not previously been treated for the disease, which is diagnosed annually in almost 23,000 …

View Post

Ancient anti-inflammatory drug salicylic acid has cancer-fighting properties

In In The News by Barbara Jacoby

Source: Gladstone Institutes From: sciencedaily.com Scientists from the Gladstone Institutes have identified a new pathway by which salicylic acid–a key compound in the nonsteroidal anti-inflammatory drugs aspirin and diflunisal–stops inflammation and cancer. In a study published in eLife, the researchers found that both salicylic acid and diflunisal suppress two key proteins that help control gene expression throughout the body. These …

View Post

Breast cancer trial destroys tumors in 11 days

In In The News by Barbara Jacoby

By: Aine McCarthy From: cancerresearchuk.com As you’ll probably have seen from this morning’s headlines, UK researchers running a clinical trial have presented some exciting preliminary results at a the tenth European Breast Cancer Conference. The trial looked at the effects of combining two drugs – trastuzumab (Herceptin) and lapatinib –before surgery, in women with HER2 positive breast cancer. Called EPHOS …

View Post

New cancer treatments offering ‘profound lease on life’

In In The News by Barbara Jacoby

By: AMY FLOWERS UMBLE From: fredericksburg.com The prognosis was grim—tumors had sprouted in Stephan Silverman’s lungs and spread to his back. “I was basically given a death sentence,” Silverman said. But the Caroline County resident didn’t feel bleak. He turned to the same spiritual practices that helped him kick a two-pack-a-day smoking habit 35 years earlier. The 73-year old also …

View Post

Noni cancer study underway

In In The News by Barbara Jacoby

By: Paula Akana From: kitv.com HONOLULU – The UH Cancer Center is taking on prostate cancer. It’s the most common cancer among men in Hawaii, and the center hopes noni extract can help make cancer no more. The noni is that pungent fruit found throughout Polynesia and Asia. The trial involves low or very low risk patients prostate cancer. Jeffrey Huang …

View Post

Breast Cancer Clinical Trial of Laser Ablation Treatment Shows Promising Results for Patients

In In The News by Barbara Jacoby

Groundbreaking Novilase Research Led by Rose Medical Center’s Dr. Barbara Schwartzberg Is Presented at San Antonio Breast Cancer Symposium A laser treatment called Novilase® Breast Therapy shows promise as a way to successfully treat small breast cancers, according to research that was led by principal investigator Barbara Schwartzberg, M.D. of Rose Medical Center. Results of the multi-center international BR-002 Novilase …

View Post

MD Anderson Begins Lymphoma Trial for Oncoceutics’ ONC201

In In The News by Barbara Jacoby

Oncoceutics, Inc. announced that patient enrollment for a clinical trial of the company’s lead compound ONC201 in non-Hodgkin’s lymphoma has started at The University of Texas MD Anderson Cancer Center (MDACC). The trial, identified as NCT02420795 on www.clinicaltrials.gov, is entitled “Phase I/II Study of Oral ONC201 in Patients with Relapsed/Refractory Non-Hodgkin’s Lymphoma.” The Phase I/II trial will investigate the use …

View Post

Enrollment Begins In ONC201 Clinical Trial Expansion Phase

In In The News by Barbara Jacoby

Hummelstown, PA – Oncoceutics, Inc. announced that the first patients have been enrolled in the expansion phase of the first-in-man clinical trial with C201 at the Rutgers Cancer Institute of New Jersey (CINJ).  Previously, Oncoceutics reported the completion of the dose escalation portion of the trial entitled “Oral ONC201 in Treating Patients with Advanced Solid Tumors” and identified as NCT02250781 …

View Post

For Cancer-Detecting Canines, The Nose Knows

In In The News by Barbara Jacoby

From: npr.org. A new clinical trial is set to begin in the United Kingdom using the powerful noses of dogs to detect prostate cancer in humans. While research has been done before, these are the first trials approved by Britain’s National Health Service. The trials, at the Milton Keynes University Hospital in Buckinghamshire, will use animals from a nonprofit organization …